Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

Post by monarkaon Jan 28, 2019 9:00am
269 Views
Post# 29288433

News

News

MONTRALJan. 28, 2019 /CNW Telbec/ -  LGC Capital Ltd. (the "Corporation" or "LGC") (TSXV: LG) has delayed the filing of its audited annual financial statements for the year ended September 30, 2018, its related Management's Discussion and Analysis, and the Chief Executive Officer and Chief Financial Officer certifications (the "Required Filings"). The Corporation anticipates to be in a position to file the Required Filings no later than February 15, 2019.

Many of LGC's investments are in the form of convertible debentures and net sales royalties in private cannabis companies.  The principle reason behind the Corporation's delay in meeting its reporting deadline can be directly attributable to the complexities of establishing the fair values under IFRS of these financial instruments in respect to the these private cannabis companies.

The Corporation's Required Filings will be made as soon as the Board of Directors has approved the financial statements and its auditors have delivered their final audit report.  

Application for Management Cease Trade Order

The Corporation has made an application to the Autorit des marchs financiers for a management cease trade order ("MCTO"), which would restrict all trading in securities of the Corporation, whether direct or indirect, by the Chief Executive Officer, Chief Financial Officer and directors of the Corporation. There is no guarantee that an MCTO will be granted. The issuance of an MCTO does not generally affect the ability of persons who are not executive officers or directors of LGC to trade in securities of the Corporation.

If the MCTO is granted, the Corporation intends to comply with the provisions of the alternative information guidelines as set out in the Policy Statement 12-203 respecting Management Cease Trade Orders for as long as it remains in default, including the issuance of bi-weekly default status reports, each of which will be issued in the form of a news release. The Corporation will also continue to disclose any other material information concerning its affairs and ongoing business activities.

<< Previous
Bullboard Posts
Next >>